{"id":"ovitrelle-hcg-250-mcg","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Injection site reactions (pain, erythema, bruising)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Abdominal pain or discomfort"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"hCG binds to luteinizing hormone (LH) receptors on ovarian cells, inducing the final stages of meiosis I completion and triggering the release of a mature egg from the ovarian follicle. This synthetic hCG is used as a substitute for the natural LH surge that normally occurs mid-cycle, allowing precise timing of ovulation in fertility treatment protocols.","oneSentence":"Ovitrelle is a recombinant human chorionic gonadotropin (hCG) that mimics the natural hormone to trigger final oocyte maturation and ovulation in assisted reproductive cycles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:59:06.248Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles"},{"name":"Ovulation triggering in controlled ovarian hyperstimulation for in vitro fertilization (IVF)"}]},"trialDetails":[{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":"Infertility Female, Frozen Embryo Transfer (FET)","enrollment":120},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":"Embryo Transfer, Irregular Menstruation, Letrozole","enrollment":790},{"nctId":"NCT06875752","phase":"PHASE4","title":"Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-04-12","conditions":"Luteal Support, Frozen Embryo Transfer (FET)","enrollment":180},{"nctId":"NCT06896617","phase":"PHASE4","title":"Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2025-02-01","conditions":"Infertilities, Embryo Transfer","enrollment":334},{"nctId":"NCT03660813","phase":"NA","title":"Follicle Size and Oocyte Development","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2018-07-01","conditions":"IVF Treatment","enrollment":200},{"nctId":"NCT02368964","phase":"NA","title":"IVF Treatment in Women With Immature Oocytes in Previous Cycle","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2015-02-01","conditions":"Infertility","enrollment":100},{"nctId":"NCT05321511","phase":"PHASE4","title":"Comparison of Triggers in Double Ovarian Stimulation (DuoStim).","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2022-03-03","conditions":"IVF, LOW OVARIAN RESPONSE","enrollment":165},{"nctId":"NCT01297465","phase":"PHASE3","title":"PERgoveriS In Stratified Treatment for Assisted Reproductive Technique","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2011-05-31","conditions":"Assisted Reproductive Techniques, Reproductive Technology, Assisted","enrollment":202},{"nctId":"NCT00747617","phase":"PHASE3","title":"Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2007-09","conditions":"Polycystic Ovary Syndrome","enrollment":25},{"nctId":"NCT03540979","phase":"NA","title":"Endometrial Preparation in Frozen Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2018-06","conditions":"Reproductive Behavior","enrollment":100},{"nctId":"NCT03480412","phase":"","title":"Second Step Protocol in Poor Ovarian Responder (POR)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-09-01","conditions":"Infertility, Female, Premature Ovarian Failure, Fertility Disorders","enrollment":50},{"nctId":"NCT00249834","phase":"PHASE4","title":"Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-09-22","conditions":"Infertility","enrollment":166},{"nctId":"NCT03440359","phase":"PHASE2, PHASE3","title":"Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2012-07-06","conditions":"Polycystic Ovary Syndrome","enrollment":52},{"nctId":"NCT02047227","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2014-01-31","conditions":"Infertility","enrollment":939},{"nctId":"NCT02825290","phase":"PHASE4","title":"Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-07","conditions":"Embryo Transfer, Luteal Support","enrollment":62},{"nctId":"NCT02862782","phase":"PHASE3","title":"Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2016-09","conditions":"In-vitro Fertilization","enrollment":1000},{"nctId":"NCT01653743","phase":"PHASE3","title":"Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-09","conditions":"Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction","enrollment":81},{"nctId":"NCT00953628","phase":"PHASE4","title":"Endometrial Advancement After Rec or u-HCG Triggering","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2005-08","conditions":"Infertility","enrollment":130},{"nctId":"NCT01497197","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-05","conditions":"Infertility, Fertility, Follicle Stimulating Hormone Deficiency","enrollment":174},{"nctId":"NCT02048891","phase":"PHASE4","title":"Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2014-10","conditions":"Infertility","enrollment":3},{"nctId":"NCT01279200","phase":"PHASE4","title":"Use of High Cost Monitoring During Letrozole Ovulation Induction","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2011-01","conditions":"Infertility","enrollment":21},{"nctId":"NCT01081756","phase":"PHASE3","title":"A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2003-12","conditions":"Infertility","enrollment":218},{"nctId":"NCT01616225","phase":"PHASE2, PHASE3","title":"Growth Hormone in Poor Responders to IVF Trial","status":"TERMINATED","sponsor":"Pacific Centre for Reproductive Medicine","startDate":"2012-06","conditions":"Infertility","enrollment":60},{"nctId":"NCT01080729","phase":"","title":"An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-02","conditions":"Multifollicular Stimulation","enrollment":25},{"nctId":"NCT00298025","phase":"PHASE4","title":"A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-09","conditions":"Infertile Women Undergoing Assisted Reproductive Technology (ART)","enrollment":185},{"nctId":"NCT01079949","phase":"PHASE2","title":"A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-11","conditions":"Infertility, Ovulation Induction","enrollment":93},{"nctId":"NCT00505752","phase":"PHASE2","title":"Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-01","conditions":"Infertility","enrollment":520},{"nctId":"NCT00553514","phase":"PHASE2","title":"AS900672-Enriched in Ovulation Induction","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-12","conditions":"Ovulation Induction","enrollment":71},{"nctId":"NCT01185704","phase":"PHASE3","title":"Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Polycystic Ovarian Syndrome","enrollment":136},{"nctId":"NCT01210144","phase":"PHASE4","title":"EXpression PRofile Endometrium Samples Study","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":27},{"nctId":"NCT00230815","phase":"PHASE3","title":"A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2004-07","conditions":"Infertility","enrollment":62},{"nctId":"NCT01668056","phase":"NA","title":"Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-01","conditions":"Infertility","enrollment":30},{"nctId":"NCT00328926","phase":"PHASE4","title":"Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2006-03","conditions":"Hypogonadotropic Hypogonadism","enrollment":11},{"nctId":"NCT01662180","phase":"","title":"Predicting Ovarian Response in Artificial Insemination With Low Stimulation","status":"UNKNOWN","sponsor":"Isala","startDate":"2012-12","conditions":"Subfertility","enrollment":510},{"nctId":"NCT00883766","phase":"NA","title":"Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2009-04","conditions":"Polycystic Ovary Syndrome, In Vitro Fertilization","enrollment":172},{"nctId":"NCT01205009","phase":"NA","title":"Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2011-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT00954265","phase":"PHASE3","title":"Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2005-08","conditions":"Embryonic Development, Pregnancy, VEGF","enrollment":130},{"nctId":"NCT00398229","phase":"PHASE2","title":"hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2006-11","conditions":"Fertility Agents, Female","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ovitrelle ( Hcg 250 mcg)","genericName":"Ovitrelle ( Hcg 250 mcg)","companyName":"Fundacion Clinic per a la Recerca Biomédica","companyId":"fundacion-clinic-per-a-la-recerca-biom-dica","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ovitrelle is a recombinant human chorionic gonadotropin (hCG) that mimics the natural hormone to trigger final oocyte maturation and ovulation in assisted reproductive cycles. Used for Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles, Ovulation triggering in controlled ovarian hyperstimulation for in vitro fertilization (IVF).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}